Compounds > tetrachloroisophthalonitrile
Page last updated: 2024-08-21

tetrachloroisophthalonitrile and Bladder Cancer

tetrachloroisophthalonitrile has been researched along with Bladder Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Grobet-Jeandin, E; Pinar, U; Rouprêt, M1
Kulkarni, GS1
Noon, AP; Pang, KH1

Other Studies

3 other study(ies) available for tetrachloroisophthalonitrile and Bladder Cancer

ArticleYear
Re: Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
    European urology, 2022, Volume: 81, Issue:4

    Topics: BCG Vaccine; Cystectomy; Feasibility Studies; Female; Humans; Male; Nitriles; Urinary Bladder Neoplasms

2022
Re: Radical Cystectomy Against Intravesical BCG for High-risk High-grade Nonmuscle Invasive Bladder Cancer: Results from the Randomized Controlled BRAVO-feasibility Study.
    European urology, 2021, Volume: 80, Issue:3

    Topics: BCG Vaccine; Cystectomy; Feasibility Studies; Humans; Nitriles; Urinary Bladder Neoplasms

2021
Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study.
    European urology, 2018, Volume: 73, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Intravesical; BCG Vaccine; Cystectomy; Feasibility Studies; Humans; Immunotherapy; Nitriles; Urinary Bladder Neoplasms

2018